Evaluation of Epidemiological Disease Burden of Endometriosis Based on Routinely Collected Health Data Between 2010 and 2019
Author(s)
Dalma Pónusz-Kovács, MSc1, Luca F. Kajos, MSc1, Tímea Csákvári, MSc, PhD2, Róbert Pónusz, MSc, PhD1, Bettina Kovács, MSc1, Ákos Várnagy, MD, Ph.D., Habil3, József Bódis, MD, Ph.D., Habil3, Imre Boncz, MSc, PhD, MD1;
1University of Pécs, Faculty of Health Sciences, Institute for Health Insurance, Pécs, Hungary, 2University of Pécs, Faculty of Health Sciences, Institute for Health Insurance, Zalaegerszeg, Hungary, 3University of Pécs, National Laboratory on Human Reproduction, Pécs, Hungary
1University of Pécs, Faculty of Health Sciences, Institute for Health Insurance, Pécs, Hungary, 2University of Pécs, Faculty of Health Sciences, Institute for Health Insurance, Zalaegerszeg, Hungary, 3University of Pécs, National Laboratory on Human Reproduction, Pécs, Hungary
Presentation Documents
OBJECTIVES: Endometriosis is one of the most common gynecological diseases that could lead to infertility. The aim of quantitative, descriptive, and cross-sectional study is to analyze the prevalence and the annual nationwide health insurance treatment cost of endometriosis in Hungary in 2010 and 2019.
METHODS: The data used in this study was from publicly funded national real-world datasets administered by the National Health Insurance Fund Administration (NHIFA). The total number of endometriosis cases in the Hungarian population was evaluated by WHO ICD codes (Xth revision). The total prevalence in annual basis, the age-specific prevalence, the mean age of patients and cases by the type of received infertility treatment were evaluated.
RESULTS: The highest number of patients and prevalence were found in outpatient care (2010. 101.9/100,000 women; 2019. 197.3/ 100,000 women). A three-times higher annual number of cases was registered in 2019 related to CT and MRI diagnostics compared to 2010 (+773 cases). In 2019, the highest utilization was calculated for the 30-39-year age group (2.0 times higher than in 2010). The mean Length of Stay (LoS) for patients with endometriosis was 3.9 days in 2010, which decreased to 2.8 days in 2019. There was a significant correlation between length of stay and mean age of patients in both years (2010 r=0.856, p<0.001; 2019 r=0.877, p<0.001).
CONCLUSIONS: The number of endometriosis cases is increasing. It affects patient mostly in economically active years; however, it has a significant impact on patients in reproductive years as well. Early diagnosis and targeted treatment, while reducing endometriosis symptoms, would improve patients' quality of life and reduce health insurance costs. The further policy involvement with a goal to improve the accessibility of treatment would have result a significant impact on effective patient outcomes.
METHODS: The data used in this study was from publicly funded national real-world datasets administered by the National Health Insurance Fund Administration (NHIFA). The total number of endometriosis cases in the Hungarian population was evaluated by WHO ICD codes (Xth revision). The total prevalence in annual basis, the age-specific prevalence, the mean age of patients and cases by the type of received infertility treatment were evaluated.
RESULTS: The highest number of patients and prevalence were found in outpatient care (2010. 101.9/100,000 women; 2019. 197.3/ 100,000 women). A three-times higher annual number of cases was registered in 2019 related to CT and MRI diagnostics compared to 2010 (+773 cases). In 2019, the highest utilization was calculated for the 30-39-year age group (2.0 times higher than in 2010). The mean Length of Stay (LoS) for patients with endometriosis was 3.9 days in 2010, which decreased to 2.8 days in 2019. There was a significant correlation between length of stay and mean age of patients in both years (2010 r=0.856, p<0.001; 2019 r=0.877, p<0.001).
CONCLUSIONS: The number of endometriosis cases is increasing. It affects patient mostly in economically active years; however, it has a significant impact on patients in reproductive years as well. Early diagnosis and targeted treatment, while reducing endometriosis symptoms, would improve patients' quality of life and reduce health insurance costs. The further policy involvement with a goal to improve the accessibility of treatment would have result a significant impact on effective patient outcomes.
Conference/Value in Health Info
2025-05, ISPOR 2025, Montréal, Quebec, CA
Value in Health, Volume 28, Issue S1
Code
EPH46
Topic
Epidemiology & Public Health
Topic Subcategory
Public Health
Disease
SDC: Reproductive & Sexual Health